GENKYOTEX SA has a total of 96 patent applications. Its first patent ever was published in 2008. It filed its patents most often in EPO (European Patent Office), Republic of Korea and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are AMNESTIX INC, TIANJIN TIANSHILI PHARMACEUTIC and CAVALLA DAVID.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 16 | |
#2 | Republic of Korea | 10 | |
#3 | WIPO (World Intellectual Property Organization) | 10 | |
#4 | Canada | 9 | |
#5 | China | 9 | |
#6 | Hong Kong | 9 | |
#7 | Brazil | 8 | |
#8 | Israel | 8 | |
#9 | United States | 6 | |
#10 | Serbia | 4 | |
#11 | Australia | 3 | |
#12 | Japan | 2 | |
#13 | Mexico | 1 | |
#14 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Page Patrick | 71 |
#2 | Gaggini Francesca | 59 |
#3 | Orchard Mike | 55 |
#4 | Laleu Benoit | 48 |
#5 | Laleu Benoît | 9 |
#6 | Patrick Page | 9 |
#7 | Brandes Ralf | 8 |
#8 | Fioraso-Cartier Laetitia | 8 |
#9 | Mottironi Bianca | 8 |
#10 | Benoit Laleu | 7 |
Publication | Filing date | Title |
---|---|---|
EP3098220A1 | Process for the preparation of a nadph oxidase inhibitor and its polymorphs and uses thereof | |
EP3034500A1 | Amido thiazole derivatives as NADPH oxidase inhibitors | |
EP2857399A1 | Compounds useful for the treatment of PDE5 inhibitor-poorly responsive erectile dysfunction | |
EP2361911A1 | Pyrazolo piperidine derivatives as NADPH oxidase inhibitors | |
EP2361912A1 | Pyrazolo piperidine derivatives as NADPH oxidase inhibitors | |
EP2305679A1 | Pyrazoline dione derivatives as nadph oxidase inhibitors | |
WO2010035221A1 | Pyrazolo pyridine derivatives as nadph oxidase inhibitors | |
EP2139472A1 | Tetrahydroindole derivatives as nadph oxidase inhibitors | |
EP2545918A1 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |